These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38646483)

  • 1. Cytokine profiles of mild-to-moderate SARS-CoV-2 infected and recovered pre-vaccinated individuals residing in Indonesia.
    Megasari NLA; Khairunisa SQ; Arizandy RY; Wijaksana IKE; Wungu CDK
    PeerJ; 2024; 12():e17257. PubMed ID: 38646483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex array analysis of circulating cytokines and chemokines in COVID-19 patients during the first wave of the SARS-CoV-2 pandemic in Milan, Italy.
    Calvo-Alvarez E; D'Alessandro S; Zanotta N; Basilico N; Parapini S; Signorini L; Perego F; Maina KK; Ferrante P; Modenese A; Pizzocri P; Ronsivalle A; Delbue S; Comar M
    BMC Immunol; 2024 Jul; 25(1):49. PubMed ID: 39061002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term changes in the phenotype and cytokine production of monocytes in COVID-19 recovered and vaccinated individuals.
    Ostapchuk YO; Lushova AV; Kan SA; Abdolla N; Kali A; Tleulieva R; Perfilyeva AV; Perfilyeva YV
    Infect Immun; 2024 Jul; 92(7):e0021624. PubMed ID: 38874358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
    Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
    PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study.
    Zhu X; Gebo KA; Abraham AG; Habtehyimer F; Patel EU; Laeyendecker O; Gniadek TJ; Fernandez RE; Baker OR; Ram M; Cachay ER; Currier JS; Fukuta Y; Gerber JM; Heath SL; Meisenberg B; Huaman MA; Levine AC; Shenoy A; Anjan S; Blair JE; Cruser D; Forthal DN; Hammitt LL; Kassaye S; Mosnaim GS; Patel B; Paxton JH; Raval JS; Sutcliffe CG; Abinante M; Broderick P; Cluzet V; Cordisco ME; Greenblatt B; Petrini J; Rausch W; Shade D; Lane K; Gawad AL; Klein SL; Pekosz A; Shoham S; Casadevall A; Bloch EM; Hanley D; Sullivan DJ; Tobian AAR
    Lancet Microbe; 2023 Sep; 4(9):e692-e703. PubMed ID: 37659419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.
    Azmy V; Kaman K; Tang D; Zhao H; Dela Cruz C; Topal JE; Malinis M; Price CC
    J Clin Immunol; 2021 May; 41(4):738-747. PubMed ID: 33459964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2.
    Ramos-Martinez E; Falfán-Valencia R; Pérez-Rubio G; Andrade WA; Rojas-Serrano J; Ambrocio-Ortiz E; Galicia-Álvarez DS; Bárcenas-Montiel I; Velasco-Medina A; Velázquez-Sámano G
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the plasma proteome persist ten months after recovery from mild to moderate SARS-CoV-2 infection.
    Huapaya JA; Gairhe S; Kanth S; Tian X; Demirkale CY; Regenold D; Sun J; Lynch NF; Luo R; Forsberg A; Dewar R; Rehman T; Li W; Krack J; Kuruppu J; Aboye EA; Barnett C; Strich JR; Davey R; Childs R; Chertow D; Kovacs JA; Torabi-Parizi P; Suffredini AF
    Front Immunol; 2024; 15():1448780. PubMed ID: 39324144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.
    Ling L; Chen Z; Lui G; Wong CK; Wong WT; Ng RWY; Tso EYK; Fung KSC; Chan V; Yeung ACM; Hui DSC; Chan PKS
    Front Immunol; 2021; 12():763292. PubMed ID: 34938289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity.
    Tejedor Vaquero S; de Campos-Mata L; Ramada JM; Díaz P; Navarro-Barriuso J; Ribas-Llaurado C; Rodrigo Melero N; Carolis C; Cerutti A; Gimeno R; Magri G
    Front Immunol; 2021; 12():737083. PubMed ID: 34539673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection.
    Tripathy AS; Vishwakarma S; Trimbake D; Gurav YK; Potdar VA; Mokashi ND; Patsute SD; Kaushal H; Choudhary ML; Tilekar BN; Sarje P; Dange VS; Abraham P
    Arch Virol; 2021 Dec; 166(12):3301-3310. PubMed ID: 34554303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine and chemokine profiles in the sera of COVID-19 patients with different stages of severity.
    Bourhis M; Idir A; Machraoui S; Hachimi A; Elouardi Y; Jamil O; Khallouki M; Zahlane K; Guennouni M; Hazime R; Essaadouni L; Lourhlam B; Ennaji MM; Mouse HA; Admou B; Zyad A
    Cytokine; 2024 Aug; 180():156653. PubMed ID: 38781873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
    Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
    Front Immunol; 2021; 12():668725. PubMed ID: 34276659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
    Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021.
    Budziar W; Gembara K; Harhala M; Szymczak A; Jędruchniewicz N; Baniecki K; Pikies A; Nahorecki A; Hoffmann A; Kardaś A; Szewczyk-Dąbrowska A; Klimek T; Kaźmierczak Z; Witkiewicz W; Barczyk K; Dąbrowska K
    PLoS One; 2022; 17(2):e0253638. PubMed ID: 35113873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals.
    Klingler J; Lambert GS; Itri V; Liu S; Bandres JC; Enyindah-Asonye G; Liu X; Simon V; Gleason CR; Kleiner G; Chiu HP; Hung CT; Kowdle S; Amanat F; Lee B; Zolla-Pazner S; Upadhyay C; Hioe CE
    Front Immunol; 2021; 12():759688. PubMed ID: 34987505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients.
    Guo Y; Li T; Xia X; Su B; Li H; Feng Y; Han J; Wang X; Jia L; Bao Z; Li J; Liu Y; Li L
    Front Immunol; 2021; 12():723585. PubMed ID: 34489974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.